Elementary studies on elevated steroidogenic factor-1 expression in aldosterone-producing adenoma

Abstract Objectives The expression of steroidogenic factor-1 (SF-1) was elevated in adrenal aldosterone-producing adenoma (APA). The influence of SF-1 on adrenal tumorigenesis by adrenocortical cell line H295R cells was investigated. Materials and methods Real-time PCR and Western blotting were used...

Full description

Saved in:
Bibliographic Details
Published inUrologic oncology Vol. 30; no. 4; pp. 457 - 462
Main Authors Hu, Dongliang, M.D, Ouyang, Jinzhi, M.D, Wu, Zhun, M.D, Shi, Taoping, M.D, Wang, Baojun, M.D, Ma, Xin, M.D, Li, Hongzhao, M.D, Wang, Shaogang, M.D, Zhang, Xu, M.D
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.07.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objectives The expression of steroidogenic factor-1 (SF-1) was elevated in adrenal aldosterone-producing adenoma (APA). The influence of SF-1 on adrenal tumorigenesis by adrenocortical cell line H295R cells was investigated. Materials and methods Real-time PCR and Western blotting were used to detect SF-1 expression in 16 APA samples and 12 normal adrenal samples. Specific SF-1-shRNA plasmid was transfected into H295R cells to inhibit SF-1 expression. Western blotting and real-time PCR were used to verify the effects of RNAi on SF-1 inhibition. Subsequently, WST-1 and cell count were applied to evaluate cell proliferation at different SF-1 levels. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was used to measure cell apoptosis, and proliferation marker Ki-67 was studied by immunohistochemistry. Results Compared with normal adrenal samples, SF-1 mRNA and protein levels in APA samples were significantly higher. It was 10.48:1 at SF-1 mRNA and 0.87 ± 0.05 vs. 0.39 ± 0.07 at protein levels, respectively ( P < 0.01). A decreased SF-1 significantly inhibited cell proliferation in the experimental and control cells. These results were supported by weaker Ki-67 staining in SF-1-inhibited cells [(36.9% ± 4.17%) vs. (58.48% ± 7.16%) ( P < 0.01)]. Moreover, SF-1 inhibition induced a 2.7-fold increase in the percentage of apoptotic H295R cells ( P < 0.01). Conclusions Elevated SF-1 may play an important role in APA formation and primary aldosteronism. SF-1 acts as an oncogenic factor, and its inhibition provides new insight into the understanding and treatment of related adrenal diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2010.03.001